Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by aldo451on Apr 22, 2019 1:24pm
129 Views
Post# 29655204

RE:RE:RE:sp moving up instead of down..

RE:RE:RE:sp moving up instead of down..At this point it is not clear if the Rights Offering will be available to new shareholders after the conversion. If so, the 5B shares at $0.015 could be exercised by the holders of 20B new shares, that's 1/4 share per 1 share currently owned if they all bought in!

I asked Fred, he is looking into this and will get back to me with a "final and verified" answer.

From the PR

a rights offering to all shareholders of Prometic whereby each shareholder will receive one right for each Common Share held, with each right entitling theholder thereof to subscribe for 20 Common Shares at a price per share equal to the Transaction Price (i.e. a per share price of $0.01521), for aggregateproceeds to Prometic of up to $75 million, which will commence following the closing of the above-mentioned transactions (the "Rights Offering" andcollectively with the Private Placeme t, Debt Conversion and the Warrant Repricing, the "Refinancing Transactions").
 


Newcamo wrote:

u dont get it... the rights compensate somewhat for dilution (u will get new shares amount to be somewhere between 7x-20x amount u own now), and those shares u will pay 0,015$...so yes u can compensate big time your losses....and fast in view of how it trades and news coming.

People should understand this, stop b.s. talk about class action, lawyers that will not reward you as much and as fast as these rights...

Bullboard Posts